epocrates logo
epocrates logo
epocrates logo
  • 0

Drugs

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Formulary
No Formulary Selected

Classes

  • All Drugs
  • Allergy/Cold/ENT
  • Anesthesia/Pain Management
  • Asthma/Pulmonary
  • Cardiovascular
  • Dental/Oral Care
  • Dermatologic
  • Diagnostic
  • Emergency
  • Endocrine/Metabolism
  • Gastrointestinal
  • Hematology/Oncology
  • Immunizations
  • Immunology
  • Infectious Disease
  • Nephrology/Urology
  • Neurologic
  • Nutrition/Electrolytes
  • Obstetrics/Gynecology
  • Ophthalmic
  • Psychiatric
  • Rheumatologic

Asthma/ Pulmonary

Subclasses

  • Adrenergic Agonists (Nonselective), Pulmonary
  • Alpha1-Proteinase Inhibitors
  • Antimicrobials, Inhaled
  • Beta-2 Agonists, Inhaled Long-Acting (LABAs)
  • Beta-2 Agonists, Inhaled Short-Acting (SABAs)
  • Beta-2 Agonists, Oral
  • Corticosteroids, Inhaled
  • Cystic Fibrosis
  • Diagnostic Agents, Pulmonary
  • Dipeptidyl Peptidase-1 (DPP-1) Inhibitors
  • Expectorants/ Mucolytics
  • IgE Antagonists
  • Interleukin-4/ 13 (IL-4/ 13) Antagonists
  • Interleukin-5 (IL-5) Antagonists
  • Interstitial Lung Disease
  • Leukotriene Inhibitors
  • Mast Cell Stabilizers, Inhaled
  • Methylxanthines, Pulmonary
  • Muscarinic Antagonists, Inhaled Long-Acting (LAMAs)
  • Muscarinic Antagonists, Inhaled Short-Acting (SAMAs)
  • Phosphodiesterase 3/ 4 (PDE3/ 4) Inhibitors, Pulmonary
  • Phosphodiesterase 4 (PDE4) Inhibitors, Pulmonary
  • Respiratory Stimulants, Central
  • Respiratory Syncytial Virus (RSV)
  • Sclerosing Agents, Pulmonary
  • Sleep-related Breathing Disorders
  • Surfactants
  • Thymic Stromal Lymphopoietin (TSLP) Antagonists

Expectorants/ Mucolytics

Drug Names

Generic Names

acetylcysteine generic  
guaifenesin generic  
Mucinex guaifenesin  
Mucinex Maximum Strength guaifenesin  
Mucomyst acetylcysteine  
Pulmozyme dornase alfa inhaled  
SSKI potassium iodide  

close

 

Select a medication above to begin.

methylphenidate

generic

Drug Monograph

  • Black Box Warnings
  • Adult Dosing
  • Peds Dosing
  • Contraindications/Cautions
  • Drug Interactions
  • Adverse Reactions
  • Safety/Monitoring
  • Pregnancy/Lactation
  • Pharmacology
  • Formulary
  • Manufacturer/Pricing
  • Patient Education
  • Pill Pictures
  • Add to Interaction Check
  • Dosing Calculator

Black Box Warnings .

Abuse, Misuse, and Addiction

CNS stimulants have high potential for abuse and misuse, can lead to substance use disorder, including addiction; misuse and abuse can result in overdose and death, risk incr. with higher doses or unapproved administration methods; assess risk for abuse, misuse, and addiction before prescribing and throughout tx; educate patients and families about risks and proper drug storage and disposal; monitor frequently for signs/symptoms of abuse, misuse, and addiction during tx

Adult Dosing .

Dosage forms:  ER CAP (qd, 50% IR/50% DR): 10 mg, 20 mg, 30 mg, 40 mg, 60 mg; ER CAP (qd, 40% IR/60% ER): 10 mg, 15 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg; ER CAP (qd, 30% IR/70% ER): 10 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg; TAB: 5 mg, 10 mg, 20 mg; ER TAB (qd-bid): 10 mg, 20 mg; ER TAB (qd): 18 mg, 27 mg, 36 mg, 54 mg, 72 mg; CHEWABLE: 2.5 mg, 5 mg, 10 mg; SOLUTION: 5 mg per 5 mL, 10 mg per 5 mL

Special Note

[strength clarification]
Info: all strengths expressed as methylphenidate hydrochloride
[equivalency or interchangeability info]
Info: methylphenidate ER products not interchangeable; do not substitute on a mg to mg basis

ADHD

[immediate-release form]
Dose: 10-60 mg/day PO divided bid-tid; Start: 5-10 mg PO bid, may incr. by 5-10 mg/day q7 days; Max: 60 mg/day; Info: duration 3-5h; give 30-45min before meals, last dose before 6pm; give chewable tab with full glass of water
[qd extended-release cap (50% IR/50% ER) (off-label)]
Dose: 20-40 mg ER PO qam; Start: 10-20 mg ER PO qam, may incr. by 10 mg/day q7 days; Max: 60 mg/day; Info: duration 6-9h; may open ER cap, but do not crush/chew contents; may convert from IR bid to ER at same total daily dose qam; retitrate if switching between methylphenidate ER products
[qd extended-release cap (40% IR/60% ER)]
Dose: 10-60 mg ER PO qam; Start: 10 mg ER PO qam, may incr. by 10 mg/day q7 days; Max: 60 mg/day; Info: duration 12h; give consistently with or without food; may open ER cap, but do not crush/chew contents
[qd extended-release cap (30% IR/70% ER) (off-label)]
Dose: 20-60 mg ER PO qam; Start: 20 mg ER PO qam, may incr. by 10-20 mg/day q7 days; Max: 60 mg/day; Info: duration 6-9h; give before meal; may open ER cap, but do not crush/chew contents
[qd-bid extended-release tab]
Dose: 10-20 mg ER PO qd-bid; Start: 10-20 mg ER PO qam, may incr. by 10 mg/day q7 days; Max: 60 mg/day; Info: duration 2-8h; give 30-45min before meals; do not cut/crush/chew ER tab; may convert from IR to ER at same total daily dose
[qd extended-release tab]
Dose: 18-72 mg ER PO qam; Start: 18-36 mg ER PO qam, may incr. by 18 mg/day q7 days; Max: 72 mg/day; Info: for patients 18-65 yo; duration 12h; do not cut/crush/chew ER tab; see pkg insert for conversion from IR form

narcolepsy

[immediate-release form]
Dose: 10-60 mg/day PO divided bid-tid; Start: 5-10 mg PO bid, may incr. by 5-10 mg/day q7 days; Max: 60 mg/day; Info: give 30-45min before meals, last dose before 6pm; give chewable tab with full glass of water
[qd-bid extended-release tab]
Dose: 10-20 mg ER PO qd-bid; Start: 10-20 mg ER PO qam, may incr. by 10 mg/day q7 days; Max: 60 mg/day; Info: give 30-45min before meals; do not cut/crush/chew ER tab; may convert from IR to ER at same total daily dose

renal dosing

[not defined]
renal impairment: not defined
HD/PD: not defined

hepatic dosing

[not defined]

Peds Dosing .

Dosage forms:  ER CAP (qd, 50% IR/50% DR): 10 mg, 20 mg, 30 mg, 40 mg, 60 mg; ER CAP (qd, 40% IR/60% ER): 10 mg, 15 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg; ER CAP (qd, 30% IR/70% ER): 10 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg; TAB: 5 mg, 10 mg, 20 mg; ER TAB (qd-bid): 10 mg, 20 mg; ER TAB (qd): 18 mg, 27 mg, 36 mg, 54 mg, 72 mg; CHEWABLE: 2.5 mg, 5 mg, 10 mg; SOLUTION: 5 mg per 5 mL, 10 mg per 5 mL

Special Note

[strength clarification]
Info: all strengths expressed as methylphenidate hydrochloride
[equivalency or interchangeability info]
Info: methylphenidate ER products not interchangeable; do not substitute on a mg to mg basis

ADHD

[immediate-release form, 4-5 yo (off-label)]
Dose: 2.5-7.5 mg PO tid; Start: 2.5 mg PO bid, may incr. to 7.5 mg PO tid over 7 days; Max: 30 mg/day; Info: give 30-45min before meals, last dose before 6pm; give chewable tab with full glass of water
[immediate-release form, 6 yo and older]
Dose: 0.3-2 mg/kg/day PO divided bid-tid; Start: 0.3 mg/kg/dose PO bid or 2.5-5 mg PO bid, may incr. by 0.1 mg/kg/dose or 5-10 mg/day q7 days; Max: 2 mg/kg/day up to 60 mg/day; Info: duration 3-5h; give 30-45min before meals, last dose before 6pm; give chewable tab with full glass of water
[qd extended-release cap (50% IR/50% ER), 6-12 yo]
Dose: 20-40 mg ER PO qam; Start: 10-20 mg ER PO qam, may incr. by 10 mg/day q7 days; Max: 60 mg/day; Info: duration 6-9h; may open ER cap, but do not crush/chew contents; may convert from IR bid to ER at same total daily dose qam; retitrate if switching between methylphenidate ER products
[qd extended-release cap (50% IR/50% ER), 13 yo and older (off-label)]
Dose: 20-40 mg ER PO qam; Start: 10-20 mg ER PO qam, may incr. by 10 mg/day q7 days; Max: 60 mg/day; Info: duration 6-9h; may open ER cap, but do not crush/chew contents; may convert from IR bid to ER at same total daily dose qam; retitrate if switching between methylphenidate ER products
[qd extended-release cap (40% IR/60% ER), 6 yo and older]
Dose: 10-60 mg ER PO qam; Start: 10 mg ER PO qam, may incr. by 10 mg/day q7 days; Max: 60 mg/day; Info: duration 12h; give consistently with or without food; may open ER cap, but do not crush/chew contents
[qd extended-release cap (30% IR/70% ER), 6-15 yo]
Dose: 20-60 mg ER PO qam; Start: 20 mg ER PO qam, may incr. by 10-20 mg/day q7 days; Max: 60 mg/day; Info: duration 6-9h; give before meal; may open ER cap, but do not crush/chew contents
[qd-bid extended-release tab, 6 yo and older]
Dose: 10-20 mg ER PO qd-bid; Start: 10 mg ER PO qam, may incr. by 10 mg/day q7 days; Max: 60 mg/day; Info: duration 2-8h; give 30-45min before meals; do not cut/crush/chew ER tab; may convert from IR to ER at same total daily dose
[qd extended-release tab, 6-12 yo]
Dose: 18-54 mg ER PO qam; Start: 18 mg ER PO qam, may incr. by 18 mg/day q7 days; Max: 54 mg/day; Info: duration 12h; do not cut/crush/chew ER tab; see pkg insert for conversion from IR form
[qd extended-release tab, 13-17 yo]
Dose: 18-72 mg ER PO qam; Start: 18 mg ER PO qam, may incr. by 18 mg/day q7 days; Max: 2 mg/kg/day up to 72 mg/day; Info: duration 12h; do not cut/crush/chew ER tab; see pkg insert for conversion from IR form

renal dosing

[not defined]
renal impairment: not defined
HD/PD: not defined

hepatic dosing

[not defined]
Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information